PulseRider装置治疗破裂颅内动脉瘤的病例系列
本文回顾性报告2018年3月至6月在科罗拉多大学医院使用PulseRider辅助弹簧圈栓塞治疗的4例破裂宽颈基底动脉尖动脉瘤。所有动脉瘤均成功治疗,无围手术期出血及术后再破裂;2例术中发生大脑后动脉非闭塞性血栓,经动脉内糖蛋白IIb/IIIa受体拮抗剂解决;2例发生脑室外引流相关出血。作者认为该装置在急性治疗中具有前景,但需更多经验确定其地位。
要点
- 4例破裂宽颈基底动脉尖动脉瘤均成功行PulseRider辅助弹簧圈栓塞。
- 无围手术期出血及术后再破裂,2例术中发生大脑后动脉非闭塞性血栓并经动脉内糖蛋白IIb/IIIa受体拮抗剂解决。
- 2例发生脑室外引流相关出血,其中仅1例发生在双联抗血小板治疗之后。
核心结论
- PulseRider装置为支架辅助弹簧圈栓塞提供了一种新设计,作者报告了其成功用于急性治疗破裂宽颈基底动脉动脉瘤的小型但有前景的系列。
- 需要更多经验来确定该装置在破裂动脉瘤治疗武器库中是否有一席之地。
研究设计与样本
- 回顾性病例系列,2018年3月至6月在科罗拉多大学医院治疗4例破裂宽颈基底动脉尖动脉瘤,采用PulseRider辅助弹簧圈栓塞,并对每例患者进行影像和病历回顾。
主要发现
- 所有4个动脉瘤均成功接受PulseRider辅助弹簧圈栓塞。
- 无围手术期出血,无术后再破裂。
- 2例患者在弹簧圈栓塞时发生大脑后动脉非闭塞性血栓,经动脉内糖蛋白IIb/IIIa受体拮抗剂解决。
- 2例患者发生脑室外引流相关出血,其中仅1例发生在给予双联抗血小板治疗之后。
- 所有患者最终均出院回家。
关键数值与推荐
- PulseRider的官方推荐使用方案为双联抗血小板治疗(DAPT)。
- PulseRider于2017年6月获得美国食品药品监督管理局批准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 样本量小(4例)。
- 需要更多经验来确定该装置在破裂动脉瘤治疗武器库中是否有一席之地。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Wide-necked intracranial aneurysms present unique treatment challenges in the setting of subarachnoid hemorrhage. New generations of endoluminal devices (stents) have expanded our ability to treat complex aneurysms. The PulseRider Aneurysm Neck Reconstruction Device (PulseRider [Cerenovus, Irvine, California, USA]) is new to the U.S. market after receiving Food and Drug Administration approval in June 2017. Official recommendation for use of the PulseRider is with dual antiplatelet therapy (DAPT). Its design has been hypothesized to carry a lower risk of thromboembolic complications in the circumstance that DAPT needs to be discontinued. METHODS: Between March and June 2018, we treated 4 cases of ruptured wide-necked basilar tip aneurysms at the University of Colorado Hospital, Aurora, Colorado, with PulseRider-assisted coil embolization. Imaging and chart reviews were performed retrospectively on each of these patients. RESULTS: All 4 aneurysms were successfully treated with PulseRider-assisted coil embolization. There were no periprocedural hemorrhages and no postprocedural reruptures. Two patients developed nonocclusive thrombi in the posterior cerebral arteries at the time of coiling, which was resolved with intra-arterial glycoprotein IIb/IIIa receptor antagonists. Two patients developed external ventricular drain-associated hemorrhages, only one of which developed after the administration of DAPT. All patients were eventually discharged to home. CONCLUSIONS: The PulseRider device represents a novel design for stent-assisted coil embolization. We report a small but promising series of its successful use in the acute treatment of wide-necked, ruptured basilar artery aneurysms. Additional experience is needed to determine if this device has a place in our armamentarium for treatment of ruptured aneurysms.
引用
- Folzenlogen Z, Seinfeld J, Kubes S, et al. Use of the PulseRider Device in the Treatment of Ruptured Intracranial Aneurysms: A Case Series. World Neurosurg. 2019. PMID: 30862588. doi:10.1016/j.wneu.2019.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。